Krystal Biotech, Inc. <KRYS.O>: BofA Global Research raises price objective to $400 from $392
KRYS•Related News
Enphase IQ Meter Collar wins approval from 80 US, Canada utilities
ENPH•
Johnson & Johnson says Phase 3 trial shows Caplyta cuts bipolar I mania symptoms by Week 3
JNJ•
Golden Grail Beverages expands KOZ Water distribution to Technique Training in Northeast US
GOGY•
Richtech Robotics receives order to deploy 200 DUST-E cleaning robots over five years
RR•
Axcelis to sponsor, exhibit at ICSCRM 2026 silicon carbide conference
ACLS•